The global western blotting market is expected to attain a valuation of USD 980.1 million in 2023 and is projected to reach USD 1753.4 million by 2033, trailing a CAGR of 6% during the forecast period.
The market of western blotting is being propelled by several factors such as the emergence of new proteomics applications and a rise in the rates of HIV infection. The prevalence of chronic diseases and growing expenditure on healthcare research activities are also anticipated to fuel demand for western blotting.
The demand for western blotting is further driven by several significant factors, such as increasing preference for personalized medicine and a growing emphasis on maintaining a healthy lifestyle. In addition, the introduction of advanced diagnostic technologies and a heightened awareness of diseases contribute to the overall expansion of the market. The cost-effective and rapid diagnostic capabilities offered by western blotting systems are further expected to fuel the demand for this product.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 980.1 million |
| Anticipated Forecast Value (2033) | USD 1753.4 million |
| Projected Growth Rate (2023 to 2033) | CAGR 6 % |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The western blotting market was worth USD 695.7 million in 2017. It accumulated a market value of USD 924.3 million in 2022 while growing at a CAGR of 5.8% during the historical period.
The growth of western blotting manufacturers has been fueled by the consistent demand from pharmaceutical and biotechnology companies. Additionally, the expansion of research and development activities in the field of proteomics has served as an additional catalyst for the growth of industrial players in this market.
Protein research dynamics, increased investments in proteomics by biotech and pharmaceutical companies, and the rise in acquired immune deficiency syndrome (AIDS) prevalence are projected to drive the growth of the industry in the forthcoming period.
The precise analysis of protein expression in situ has transformative potential, reducing time to results and increasing throughput, thereby creating growth opportunities in the global market. The transition from traditional film-based exposure to digital imaging systems is anticipated to offer lucrative prospects for both established companies and new entrants. Furthermore, the higher selectivity and sensitivity of the western blot test, enabling precise quantification with smaller sample volumes, is expected to drive its increased application and future market growth.
The rise in research activities and increased research and development spending by pharmaceutical and biotechnology companies are further expected to create lucrative opportunities for market expansion.
The market is projected to be worth USD 1753.4 million by the end of forecast period while exhibiting a CAGR of 6%.
Use of Western Blotting to Detect Infectious Agents to Drive Market Growth
The demand for western blotting is expected to witness substantial growth due to the increasing application of the western blot test, capable of detecting protein at picogram levels. This technology finds utility in various applications, including early diagnosis, as it allows the identification of immunogenic reactions from infectious agents such as viruses and bacteria. The technique, widely used in HIV detection, utilizes both antigens and antisera, offering high specificity independent of antibody specificity. These factors drive its expanded application and contribute to the market's revenue growth.
Western blotting products, including traditional wet transfer blotting systems, chromogenic reagent kits, and more, play a vital role in scientific research, particularly in the biotechnology sector. Consequently, increased investments and related activities in this sector are anticipated to propel market growth during the forecast period.
Principal Consultant
Lack of Specialized Expertise to Restrain Market Expansion
High costs of tagged antibodies and laboratory equipment, as well as the requirement for specialized expertise to perform the test, are expected to restrain market expansion. Additionally, the time-consuming nature of western blotting compared to enzyme-linked immunosorbent assay (ELISA) and its susceptibility to inaccurate or subjective results further impede market revenue growth.
North America Driving Growth with Significant CAGR
The North American western blotting market accounted for a revenue share of 32% in 2022. The United States alone accounted for a revenue share of 29.6% in the same year. The demand outlook for western blotting in the region is expected to grow with a CAGR of 5.8% during the forecast period.
The region is expected to dominate the market of western blotting due to rising prevalence of Human Immune Deficiency (HIV) and Lyme disease across this region.
The presence of an advanced healthcare system, growing investments in proteomics research, and an increasing focus on personalized therapy and genetically engineered crops are key factors influencing the regional landscape.
The growth of the studied market in North America is expected to be driven by the increasing prevalence of chronic diseases and the rising research and development investments by pharmaceutical and biotech companies.
According to the 2022 update from the Centre for Disease Control (CDC), six in ten Americans live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes, which are the leading causes of death and disability in the region. To enhance the quality of life and mitigate risks, early diagnosis of chronic diseases is crucial, and western blotting is expected to play a significant role in this regard, thereby contributing to market growth.
Throughout the forecast period, the United States is expected to sustain its leadership position as the leading region in the North American market. The market in this region is expected to grow with a CAGR of 5.9% throughout the forecast period.
The presence of highly advanced biotechnology and medical diagnostics sectors is expected to drive the sales of western blotting products in the years to come. For example, as of October 2022, the United States Department of Health & Human Services reported that around 1.2 million individuals in the country are living with HIV, with approximately 13% of them unaware of their HIV status and in need of testing.
China Driving Growth with a Market Share above 15%
The western blotting market in China is expected to grow with a significant CAGR of 7.4% during the forecast period. The region is expected to dominate the Asia Pacific market by accumulating a 19.8% market share in 2023.
China has emerged as a highly progressive market in the rapidly growing western blotting market of Asia-Pacific. The exponential growth of the pharmaceutical industry and increasing demand from the medical diagnostics sector are driving the expansion of western blotting suppliers in China.
Rising population, booming healthcare sector, and technological advancements in the region are major factors driving industry growth.
Technological advancements in western blotting techniques, including enhanced imaging systems, automated equipment, and improved detection methods, have exerted a notable influence on the regional market. These advancements have enhanced the sensitivity, accuracy, and speed of western blotting assays, thereby driving growth in the region.
The growing emphasis on personalized medicine and targeted therapies has led to an increased demand for the identification and validation of biomarkers. This is anticipated to spur growth in the market of China.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Reagent Kits to Drive Growth with Significant CAGR
Reagent kits dominated the western blotting market by accounting for 58.81% of revenue share in 2022. The segment is expected to grow with a significant CAGR of 7.2% throughout the forecast period.
The high share and growth of these reagent consumables can primarily be attributed to their extensive use and massive consumption during the western blotting process.
Ongoing advancements in research activities, particularly in the fields of proteomics, genomics, and molecular biology, are expected to fuel the demand for reagent kits in western blotting. These kits allow for efficient and accurate protein analysis, aiding in the discovery and validation of biomarkers.
Scientific Research Propelling Growth with a Promising CAGR
In 2022, scientific research accounted for a sizeable share of 38.20% in the market of western blotting. The segment is expected to flourish at a CAGR of 7% during the forecast period.
Scientific research is currently a profitable segment in the global western blotting industry, and it is expected to maintain its position in the years ahead. The increasing number of research and development activities and advancements in the medical diagnostics sector are attractive heavy investments from key players, thereby fuelling segment growth.
Academic and research institutes extensively employ western blotting as an effective method to determine protein presence, relative abundance, relative mass, Post-Translational Modification (PTM), and protein-protein interactions. Western blotting enables researchers to identify specific proteins within complex mixtures isolated from cells. The growth of this segment is driven by increasing government spending in research activities and a surge in proteomics research endeavors.
Start-ups play a crucial role in identifying growth opportunities in various markets, including the western blotting market. Their ability to generate high returns contributes to the expansion of the industry. Start-ups are often more efficient in converting inputs into outputs and are adaptable to unpredictable market conditions. Here are some start-ups expected to drive growth in the western blotting market.
The western blotting market is extremely competitive and consists of various key industry players. These players are heavily investing in manufacturing western blotting.
The key industry players are Thermo Fisher Scientific, Inc., GE Healthcare, Hofmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation (ProteinSimple Inc.), Advansta, Inc.
Some recent developments in the market are:
Key industry players leverage organic growth strategies like acquisition, mergers, partnerships, and collaboration to enhance their product portfolio. This is expected to fuel the global western blotting market.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 980.1 million |
| Market Value in 2033 | USD 1753.4 million |
| Growth Rate | CAGR of 6% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
By product, By application, By end-user, By region |
| Regions Covered |
North America; Latin America; Europe; Asia Pacific; Middle East and Africa (MEA) |
| Key Countries Profiled |
United States of America, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, India, China, Japan, Malaysia, Singapore, Thailand, South Korea, Australia, New Zealand, UAE, South Africa, Israel, GCC countries |
| Key Companies Profiled |
Thermo Fisher Scientific, Inc.; GE Healthcare; Hofmann-La Roche Ltd.; Danaher Corporation (Lumigen, Inc.); EMD Millipore Corporation; Bio-Rad Laboratories, Inc.; PerkinElmer Inc.; LI-COR, Inc.; Bio-Techne Corporation (ProteinSimple Inc.); Advansta, Inc. |
| Customization | Available Upon Request |
The projected revenue of the market by 2033 is USD 1,753.4 million.
The market CAGR for 2033 is projected to be 6%.
North America, Europe, and Asia-Pacific are the leading market.
North America holds the largest share of the Western Blotting market.
North America is growing fast due to the high research and development activities.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Electrophoresis Blotting Systems 5.1.1. Automated Dry Blotting Systems 5.1.2. Semi-Dry Blotting Systems 5.1.3. Traditional Wet Transfer Blotting Systems 5.2. Reagent Kits 5.2.1. Chromogenic Reagent Kits 5.2.2. Chemiluminescent Reagent Kits 5.2.3. Fluorescent Reagents 5.2.4. Antibodies 5.2.5. Buffer Kits 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Research 6.2. Diagnostics 6.3. Agricultural 6.4. Food & Beverages 6.5. Other 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Diagnostic Laboratories 7.2. Research Institutions 7.3. Pharmaceutical & Biotechnology Companies 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. South Asia 8.5. East Asia 8.6. Oceania 8.7. MEA 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Thermo Fisher Scientific, Inc. 18.2. GE Healthcare 18.3. Hofmann-La Roche Ltd. 18.4. Danaher Corporation (Lumigen, Inc.) 18.5. EMD Millipore Corporation 18.6. Bio-Rad Laboratories, Inc. 18.7. PerkinElmer Inc. 18.8. LI-COR, Inc. 18.9. Bio-Techne Corporation (ProteinSimple Inc.) 18.10. Advansta, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Western Blotting Market
